Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis returns to the discount aisle, buys Xoma’s failed PhIII drug for $31M
Endpoints
Fri, 08/25/17 - 09:53 am
Tags:
Novartis, Xoma, M&A, gevokizumab, cardiovascular disease
Can Novartis' Kisqali beat Pfizer's market-leading Ibrance to reimbursement in England?
Fierce Pharma
Thu, 08/24/17 - 05:11 pm
Tags:
Novartis, Kisqali, Pfizer, Ibrance, reimbursement, breast cancer
AmerisourceBergen-owned specialty pharmacy to pay $13.4M to settle kickback allegations
Bizjournals.com
Thu, 08/24/17 - 11:28 am
Tags:
AmerisourceBergen, kickbacks, False Claims Act, Novartis, Exjade
Meet Bertrand Bodson, Novartis’ new global digital strategy maestro for all things Big Pharma
Endpoints
Thu, 08/24/17 - 10:03 am
Tags:
Novartis, digital pharma, Big Pharma
Profit finally in sight for gene therapy specialist Oxford Bio
Yahoo/Reuters
Wed, 08/23/17 - 10:07 pm
Tags:
gene therapy, Oxford BioMedica, CTL019, Novartis
New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’
Stat
Wed, 08/23/17 - 11:41 am
Tags:
CAR-T, Novartis, drug pricing, CTL019, leukemia
Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns
Fierce Pharma
Tue, 08/22/17 - 09:44 am
Tags:
Dr Reddy's, Novartis, OTC, drug ads
Novartis CEO opens door to cancer patient demanding ‘fair’ CAR-T pricing
Fierce Pharma
Tue, 08/22/17 - 12:05 am
Tags:
Novartis, Pharma CEOs, CAR-T, Joe Jimenez, drug pricing
Novartis Speeds New Anti-Malarial as Older Drug Loses Potency
Bloomberg
Mon, 08/21/17 - 09:43 am
Tags:
malaria, Novartis, KAF156
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
Thu, 08/17/17 - 11:48 pm
Tags:
multiple sclerosis, MS, drug pricing, Bayer, Biogen, Merck KGaA, Novartis, Sanofi, Teva Pharmaceutical, Roche
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
Tags:
patents, AbbVie, Humira, Pfizer, Lipitor, Norvasc, GSK, Advair, Sanofi, Lantus, JNJ, Remicade, AstraZeneca, Crestor, Nexium, Amgen, Neulasta, Novartis, Diovan
After a slow start, Novartis finally gains market traction with heart drug Entresto
Fierce Biotech
Tue, 08/15/17 - 11:14 am
Tags:
Novartis, Entresto, heart failure
Pharma's giants, new and old, tell more tales than their numbers show
Fierce Pharma
Fri, 08/11/17 - 11:16 am
Tags:
Big Pharma, JNJ, Pfizer, GSK, Roche, Novartis, Sanofi, Bristol-Myers Squibb
New Novartis rival Kisqali hasn't slowed down Pfizer's Ibrance—at least not yet
Fierce Pharma
Mon, 08/7/17 - 01:32 pm
Tags:
Novartis, Kisqali, Pfizer, Ibrance, breast cancer
Gilead Could Be Making An Acquisition — But It's Not What You Think
Investors Business Daily
Fri, 08/4/17 - 11:56 am
Tags:
Gilead Sciences, M&A, United Therapeutics, GSK, Novartis
Top Novartis manufacturing exec jumps ship, takes charge of industrializing Moderna’s mRNA tech
Endpoints
Thu, 08/3/17 - 11:06 am
Tags:
Novartis, drug manufacturing, Moderna Therapeutics, MRNA
Kite shoots for first CAR-T OK in Europe, staying one step behind Novartis in US race
Endpoints
Mon, 07/31/17 - 09:57 am
Tags:
Kite Pharma, CAR-T, Europe, Novartis, axicabtagene ciloleucel
Amgen And Novartis: First Mover Advantage Is A Must
Seeking Alpha
Mon, 07/24/17 - 11:55 pm
Tags:
Amgen, Novartis, migraines, erenumab, CGRP blockers
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
Tags:
EMA, Europe, Pfizer, Bavencio, Novartis, Rydapt, Lexicon Pharmaceuticals, Xermelo, Vanda, Fanaptum, Nektar, Onzeald, Daiichi Sankyo
Drugmakers face challenges marketing new heart drugs
Medical Marketing and Media
Sat, 07/22/17 - 10:01 am
Tags:
drug marketing, Amgen, Repatha, Novartis, Entresto, Ilaris, canakinumab, Merck, Anacetrapib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.